Call to arrange a consultation
+1 416 777 0888

Meda AB v. Canada

Represented Pharmascience in a case pursuant to the Patented Medicine (Notice of Compliance Regulations) in respect of zolpidem. Succeeded on the allegation that the Pharmascience product did not infringe the claims of the patent in issue. The decision is reported at 2016 FC 1362.

Meet the team